These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2576197)

  • 21. Synthesis and biological evaluation of 7-azaanalogues of ipsapirone.
    Malinka W; Sielklucka-Dziuba M; Rajtar G; Marowska D; Kleinrok Z
    Farmaco; 1995 Nov; 50(11):769-78. PubMed ID: 8593174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a]pyrimidine derivatives.
    Massari S; Desantis J; Nannetti G; Sabatini S; Tortorella S; Goracci L; Cecchetti V; Loregian A; Tabarrini O
    Org Biomol Chem; 2017 Sep; 15(37):7944-7955. PubMed ID: 28902220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of new pyrido[4',3':4,5]thieno[2,3-d]-1,2,4-triazolo[3,4-c]pyrimidines and a 5,6-dihydro-1,2,4-triazolo[4",3":1',2']pyrido[4',3':4,5]thieno [2,3-d]-pyrimidine ring system.
    Ahmed EK; Gohar AM; Ameen MA
    Pharmazie; 2000 Jan; 55(1):31-4. PubMed ID: 10683868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization and preliminary use of 1-, 2- and 3-methyl-5-phenyl-7-chloro-1,2,3-triazolo[4,5-d]pyrimidine as reaction intermediates.
    Biagi G; Giorgi I; Livi O; Scartoni V; Barili PL
    Farmaco; 2003 Aug; 58(8):551-6. PubMed ID: 12875884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and antitumor activity of pyrido [2,3-d]pyrimidine and pyrido[2,3-d] [1,2,4]triazolo[4,3-a]pyrimidine derivatives that induce apoptosis through G1 cell-cycle arrest.
    Fares M; Abou-Seri SM; Abdel-Aziz HA; Abbas SE; Youssef MM; Eladwy RA
    Eur J Med Chem; 2014 Aug; 83():155-66. PubMed ID: 24956552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pyrimidobenzodiazepines. Synthesis of pirenzepine analog.
    Długosz A; Machoń Z
    Pharmazie; 1990 Jul; 45(7):491-2. PubMed ID: 1978354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, Cytotoxicity, Antimicrobial and Docking Simulation of Novel Pyrazolo[3,4-d]pyrimidine and pyrazolo[4,3-e][1,2,4]triazolo[3,4-c] pyrimidine Derivatives.
    Hassaneen HM; Saleh FM; Abdallah TA; Mohamed MF; Mohamed YS; Awad EM; Abdelhamid IA
    Mini Rev Med Chem; 2019; 19(8):657-670. PubMed ID: 30332953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Organoiodine (III) mediated synthesis of 3-aryl/hetryl-5,7-dimethyl-1,2,4-triazolo[4,3-a]pyrimidines as antibacterial agents.
    Prakash O; Bhardwaj V; Kumar R; Tyagi P; Aneja KR
    Eur J Med Chem; 2004 Dec; 39(12):1073-7. PubMed ID: 15571869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor and immunosuppressive activity of Merbarone's analogues and arylidenehydrazinopyrimidines.
    Długosz A; Machoń Z
    Pharmazie; 1995 Aug; 50(8):529-34. PubMed ID: 7568316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pyrido[2, 3-d]pyrimidines and pyrimido[5',4':5, 6]pyrido[2, 3-d]pyrimidines as new antiviral agents: synthesis and biological activity.
    Nasr MN; Gineinah MM
    Arch Pharm (Weinheim); 2002 Jun; 335(6):289-95. PubMed ID: 12210772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and antimicrobial activity of certain new 1,2,4-triazolo[1,5-a]pyrimidine derivatives.
    Mostafa YA; Hussein MA; Radwan AA; Kfafy Ael-H
    Arch Pharm Res; 2008 Mar; 31(3):279-93. PubMed ID: 18409039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pyrimidines. Part II: Synthesis of novel pyrimidines, 1,2,4-triazolo[4,3-a]pyrimidin-7-ones and pyrimidino[2,1-c][1,2,4]triazin-8-ones for their antimicrobial and anticancer activities.
    Habib NS; Soliman R; Ismail K; Hassan AM; Sarg MT
    Boll Chim Farm; 2003 Nov; 142(9):396-405. PubMed ID: 14971308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel pyrimidine-2,4-dione-1,2,3-triazole and furo[2,3-d]pyrimidine-2-one-1,2,3-triazole hybrids as potential anti-cancer agents: Synthesis, computational and X-ray analysis and biological evaluation.
    Gregorić T; Sedić M; Grbčić P; Tomljenović Paravić A; Kraljević Pavelić S; Cetina M; Vianello R; Raić-Malić S
    Eur J Med Chem; 2017 Jan; 125():1247-1267. PubMed ID: 27875779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triazolopyrimidine Derivatives: An Updated Review on Recent Advances in Synthesis, Biological Activities and Drug Delivery Aspects.
    Abdelkhalek AS; Attia MS; Kamal MA
    Curr Med Chem; 2024; 31(14):1896-1919. PubMed ID: 36852819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and in vitro activity of novel 1,2,4-triazolo[4,3-a]pyrimidine oxazolidinone antibacterial agents. Part II.
    Khera MK; Cliffe IA; Prakash O
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5266-9. PubMed ID: 21835618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, characterization and cytotoxicity studies of 1,2,3-triazoles and 1,2,4-triazolo [1,5-a] pyrimidines in human breast cancer cells.
    Gilandoust M; Harsha KB; Mohan CD; Raquib AR; Rangappa S; Pandey V; Lobie PE; Basappa ; Rangappa KS
    Bioorg Med Chem Lett; 2018 Jul; 28(13):2314-2319. PubMed ID: 29789259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and antineoplastic effects of furo[3,4-d]pyrimidine derivatives.
    Machoń Z; Cieplik J
    Pol J Pharmacol Pharm; 1988; 40(2):201-8. PubMed ID: 3237569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of new pyrimidine derivatives with evaluation of their anti-inflammatory and analgesic activities.
    Nofal ZM; Fahmy HH; Zarea ES; El-Eraky W
    Acta Pol Pharm; 2011; 68(4):507-17. PubMed ID: 21796933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and pharmacological assessment of derivatives of isoxazolo[4,5-d]pyrimidine.
    Wagner E; Becan L; Nowakowska E
    Bioorg Med Chem; 2004 Jan; 12(1):265-72. PubMed ID: 14697792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluorinated 1,2,4-Triazolo[1,5-a]pyrimidine-6-carboxylic acid derivatives as antimycobacterial agents.
    Abdel-Rahman HM; El-Koussi NA; Hassan HY
    Arch Pharm (Weinheim); 2009 Feb; 342(2):94-9. PubMed ID: 19173243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.